Home・Akciju saraksts・GE HealthCare Technologies

GE HealthCare Technologies

Atvērts

SektorsVeselības aprūpe

73.66 -0.67

Pirkt Pārdot

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

73.98

Max

75.09

Galvenie mērījumi
By Trading Economics
Ienākumi	163M 574M
Pārdošana	164M 5.3B
P/E Sektora vidējais	16.988 57.371
EPS	1.13
Dividenžu ienesīgums	0.19
Peļņas marža	10.84
Darbinieki	54,000
EBITDA	198M 953M

Rekomendācijas
By TipRanks
Rekomendācijas	Pirkt
Prognoze 12 mēnešiem	+5.68% upside

Dividendes
By Acuity
Dividenžu ienesīgums Sektora vidējais	0.19% 2.23%
Nākamie ieņēmumi	2026. g. 28. okt.
Nākamais dividenžu datums	2026. g. 13. nov.
Nākamais Ex dividenžu datums	2026. g. 23. okt.

Tirgus statistika
By TradingEconomics
Tirgus kapitalizācija	5.1B 33B
Iepriekšējā atvēršanas cena	74.33
Iepriekšējā slēgšanas cena	73.66

Ziņu noskaņojums

By Acuity

28%

72%

80 / 340 Rangs Healthcare

GE HealthCare Technologies Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2026. g. 19. aug. 20:06 UTC

News

GE Healthcare Technologies appointed William Grogan as CFO, effective September 2026. BTIG reiterated its Buy rating with a $79 price target. Shares are higher since Tuesday's close.

2026. g. 18. aug. 23:51 UTC

GE Healthcare Technologies Inc. shares are higher in after-market trading, reaching above Tuesday's close despite elevated bond yields and ongoing inflation concerns.

2026. g. 17. aug. 23:11 UTC

GE Healthcare Technologies shares are higher in after-market trading, reaching a notable increase while remaining above its 20-day moving average. No specific news was identified.

2026. g. 14. aug. 19:46 UTC

GE Healthcare Technologies is trading roughly flat, with no specific news identified. Shares peaked earlier but have since settled back down.

2026. g. 13. aug. 23:46 UTC

GE Healthcare Technologies shares declined in after-market trading, reflecting a slight drop since Thursday's close. The stock remained above its 20-day moving average.

2026. g. 12. aug. 23:26 UTC

News

Trian Fund Management increased its stake in GE Healthcare Technologies to 3.1 million shares, contributing to a modest rise in after-market hours.

2026. g. 11. aug. 20:06 UTC

GE Healthcare Technologies shares are lower today amid broader market declines. The stock remains above its 20-day moving average despite earlier gains.

2026. g. 10. aug. 19:16 UTC

GE Healthcare Technologies shares are higher today, reflecting gains since Friday's close. No specific news was identified to explain the price movement.

2026. g. 7. aug. 23:36 UTC

No specific news for GE Healthcare Technologies. The stock traded roughly flat after-market, remaining near the upper end of its one-month range.

2026. g. 6. aug. 19:46 UTC

GE Healthcare Technologies remains roughly flat as price fluctuations continue. The stock trades near the upper end of its one-month range and above its moving average.

2026. g. 5. aug. 19:56 UTC

News

GE Healthcare reported strong Q2 results with $5.30 billion in revenue and adjusted EPS of $1.13, but shares are trading lower since Tuesday's close.

2026. g. 4. aug. 23:41 UTC

Shares of GE Healthcare Technologies are trading higher in after-market hours, reflecting unusual activity and remaining above the 20-day moving average.

2026. g. 3. aug. 23:01 UTC

Shares of GE Healthcare Technologies declined after-market, continuing a downward trend since Monday's close amid broader market conditions.

2026. g. 31. jūl. 23:16 UTC

News

Shares of GE Healthcare Technologies are lower in after-market trading following UBS's Neutral rating and a price target increase to $73.

2026. g. 30. jūl. 22:31 UTC

News

GE Healthcare Technologies reported Q2 revenue of $5.30 billion, but shares are trading lower after highlighting challenges in the Patient Care Solutions segment.

2026. g. 29. jūl. 23:21 UTC

GE Healthcare shares are lower in after-market hours, reflecting a decline after briefly recovering earlier in the session. No specific news was identified.

2026. g. 28. jūl. 23:41 UTC

GE Healthcare Technologies Inc. shares are higher in after-market trading, showing volatility with no specific news identified to explain the movement.

2026. g. 27. jūl. 23:16 UTC

GE Healthcare shares are trading higher in after-market hours, reflecting a modest increase since Monday's close amid positive sentiment in European markets.

2026. g. 24. jūl. 20:03 UTC

Event

News

GE Healthcare shares decline as CFO Jay Saccaro steps down amid preliminary Q2 results showing revenue growth to $5.295 billion.

2026. g. 23. jūl. 23:41 UTC

Event

News

GE Healthcare appointed George Newcomb as interim CFO and reported $5.30 billion in second-quarter revenue, with shares higher in after-market trading.

2026. g. 22. jūl. 23:31 UTC

GE Healthcare Technologies shares moved higher in after-market trading, despite earlier fluctuations. Broader market dynamics include rising crude oil prices amid U.S.-Iran tensions.

2026. g. 21. jūl. 23:46 UTC

GE Healthcare shares are higher in after-market hours amid positive market sentiment from recent earnings reports, though they remain below the 20-day moving average.

2026. g. 20. jūl. 16:31 UTC

News

GE Healthcare Technologies has launched MIM Anyware, enhancing remote access to its software portfolio. Shares are trading higher, breaking from a recent upward trend.

Salīdzinājums

Cenas izmaiņa

GE HealthCare Technologies Prognoze

Cenas mērķis

By TipRanks

5.68% augšup

Prognoze 12 mēnešiem

Vidējais 79.07 USD 5.68%

Augstākais 92 USD

Zemākais 70 USD

Pamatojoties uz 14 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi GE HealthCare Technologies — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt

14 ratings

Pirkt

Turēt

Pārdot

Pamatojoties uz 14 analītiķiem, kas pēdējo 3 mēnešu laikā snieguši akciju vērtējumus instrumentam GE HealthCare Technologies — pēdējo 3 mēnešu laikā.

Noskaņojums

By Acuity

80 / 340 Rangs Veselības aprūpe

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

Par GE HealthCare Technologies

GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, image-guided therapy, X-ray systems, and women's health products. The Ultrasound segment provides medical devices and solutions for screening, diagnosis, treatment, and monitoring of certain diseases in clinical areas, such as radiology and primary care, women's health, cardiovascular, and point of care and handheld ultrasound solutions, as well as surgical visualization and guidance products. The Patient Care Solutions segment provides medical devices, consumables, services, and digital solutions. Its portfolio includes patient monitoring solutions, anesthesia delivery and respiratory care products, electrocardiogram solutions, maternal infant care products, and consumables and services. The Pharmaceutical Diagnostics supplies diagnostic agents, including CT, angiography and X-ray, MR, single-photon emission computed tomography, positron emission tomography, and ultrasound to the radiology and nuclear medicine industry. The segment also provides contrast media pharmaceuticals that are administered to a patient prior to certain diagnostic scans to increase the visibility of tissues or structures during imaging exams; and molecular imaging agents or radiopharmaceuticals, which are molecular tracers labeled with radioisotopes. It has an AI collaboration with Mass General Brigham. The company was formerly known as GE Healthcare Holding LLC and changed its name to GE HealthCare Technologies Inc. in December 2022. The company was incorporated in 2022 and is headquartered in Chicago, Illinois.